Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1α (CCL3) after allogeneic BMT in mice by Angela Panoskaltsis-Mortari,

Slides:



Advertisements
Similar presentations
Heather J. Symons, Moshe Y
Advertisements

Recombinant CD95-Fc (APG101) prevents graft-versus-host disease in mice without disabling antitumor cytotoxicity and T-cell functions by Natalie Hartmann,
Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact.
Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease by Tangsheng Yi, Ying Chen, Lin Wang,
Host-Derived CD8+ Dendritic Cells Protect Against Acute Graft-versus-Host Disease after Experimental Allogeneic Bone Marrow Transplantation  Michael Weber,
Secondary Lymphoid Organs Contribute to, but Are Not Required for the Induction of Graft-versus-Host Responses following Allogeneic Bone Marrow Transplantation:
Expression of Chemokines in GVHD Target Organs Is Influenced by Conditioning and Genetic Factors and Amplified by GVHR  Markus Y. Mapara, Corinna Leng,
Influence of Donor Microbiota on the Severity of Experimental Graft-versus-Host- Disease  Isao Tawara, Chen Liu, Hiroya Tamaki, Tomomi Toubai, Yaping Sun,
Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers by Andrea.
In vivo retroviral gene transfer by direct intrafemoral injection results in correction of the SCID phenotype in Jak3 knock-out animals by Christine S.
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver  Alina Schreder,
Notch signaling is a critical regulator of allogeneic CD4+ T-cell responses mediating graft-versus-host disease by Yi Zhang, Ashley R. Sandy, Jina Wang,
Induction of Immunity to Neuroblastoma Early after Syngeneic Hematopoietic Stem Cell Transplantation Using a Novel Mouse Tumor Vaccine  Weiqing Jing,
by Yoshinobu Maeda, Pavan Reddy, Kathleen P
Ping Zhang, Jieying Wu, Divino Deoliveira, Nelson J. Chao, Benny J
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
by Silke Huber, Reinhard Hoffmann, Femke Muskens, and David Voehringer
In situ identification of allospecific B cells using pentamers
by Daniel L. Barber, Katrin D. Mayer-Barber, Lis R. V
Preventive Azithromycin Treatment Reduces Noninfectious Lung Injury and Acute Graft- versus-Host Disease in a Murine Model of Allogeneic Hematopoietic.
Mesenchymal Stem Cells (MSCs) Attenuate Cutaneous Sclerodermatous Graft-Versus- Host Disease (Scl-GVHD) through Inhibition of Immune Cell Infiltration.
Ikaros-Notch axis in host hematopoietic cells regulates experimental graft-versus-host disease by Tomomi Toubai, Yaping Sun, Isao Tawara, Ann Friedman,
IL-21 blockade reduces graft-versus-host disease mortality by supporting inducible T regulatory cell generation by Christoph Bucher, Lisa Koch, Christine.
B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality by Rachelle G. Veenstra, Ryan Flynn, Katharina.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor–Alpha Production in Mice after.
A Role for TNF Receptor Type II in Leukocyte Infiltration into the Lung during Experimental Idiopathic Pneumonia Syndrome  Gerhard C. Hildebrandt, Krystyna.
Targeting the Canonical Nuclear Factor-κB Pathway with a High-Potency IKK2 Inhibitor Improves Outcomes in a Mouse Model of Idiopathic Pneumonia Syndrome 
The histone methyltransferase Ezh2 is a crucial epigenetic regulator of allogeneic T-cell responses mediating graft-versus-host disease by Shan He, Fang.
Simple conditioning with monospecific CD4+CD25+ regulatory T cells for bone marrow engraftment and tolerance to multiple gene products by David-Alexandre.
by Sheng F. Cai, Xuefang Cao, Anjum Hassan, Todd A
PreImplantation Factor Reduces Graft-versus-Host Disease by Regulating Immune Response and Lowering Oxidative Stress (Murine Model)  Yehudith Azar, Reut.
IFNγ differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract by Angela C. Burman, Tatjana Banovic,
Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids.
IL-6 Blockade Attenuates the Development of Murine Sclerodermatous Chronic Graft- Versus-Host Disease  Doanh Le Huu, Takashi Matsushita, Guihua Jin, Yasuhito.
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation  Lucrezia Colonna, Mareike.
Graft-Versus-Leukemia Effect and Graft-Versus-Host Disease Can Be Differentiated by Cytotoxic Mechanisms in a Murine Model of Allogeneic Bone Marrow Transplantation.
Evelyn C. Nieves, Tomomi Toubai, Daniel C
Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease by Tangsheng Yi, Dongchang Zhao, Chia-Lei.
Volume 18, Issue 5, Pages (May 2003)
Inhibition of Cathepsin S Reduces Allogeneic T Cell Priming but Not Graft-versus-Host Disease Against Minor Histocompatibility Antigens  Hisaki Fujii,
Activated Allogeneic NK Cells as Suppressors of Alloreactive Responses
An Essential Role for IFN-γ in Regulation of Alloreactive CD8 T Cells Following Allogeneic Hematopoietic Cell Transplantation  Wannee Asavaroengchai,
Enrichment of IL-12–Producing Plasmacytoid Dendritic Cells in Donor Bone Marrow Grafts Enhances Graft-versus-Leukemia Activity in Allogeneic Hematopoietic.
Blocking Activator Protein 1 Activity in Donor Cells Reduces Severity of Acute Graft- Versus-Host Disease through Reciprocal Regulation of IL-17–Producing.
Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice  Yongxia Wu, David Bastian, Steven Schutt, Hung Nguyen,
Volume 31, Issue 1, Pages (July 2009)
T helper17 Cells Are Sufficient But Not Necessary to Induce Acute Graft-Versus-Host Disease  Cristina Iclozan, Yu Yu, Chen Liu, Yaming Liang, Tangsheng.
Volume 18, Issue 3, Pages (March 2003)
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
Effector Cells Derived from Host CD8 Memory T Cells Mediate Rapid Resistance against Minor Histocompatibility Antigen-Mismatched Allogeneic Marrow Grafts.
A Radio-Resistant Perforin-Expressing Lymphoid Population Controls Allogeneic T Cell Engraftment, Activation, and Onset of Graft-versus-Host Disease in.
Dynamic Change and Impact of Myeloid-Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice  Dapeng Wang, Yu Yu, Kelley Haarberg,
FGF-2 signaling mediates expansion of HSPCs
A CD4 Domain 1 CC′ Loop Peptide Analogue Enhances Engraftment in a Murine Model of Bone Marrow Transplantation with Sublethal Conditioning  Gabor Varadi,
Elevation of Intracellular Cyclic AMP in Alloreactive CD4+ T Cells Induces Alloantigen- Specific Tolerance That Can Prevent GVHD Lethality In Vivo  Matthew.
Tracking ex vivo-expanded CD4+CD25+ and CD8+CD25+ regulatory T cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host.
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation  Jian-Ming Li, Edmund K.
Brile Chung, Eric Dudl, Akira Toyama, Lora Barsky, Kenneth I. Weinberg 
Post-Transplantation Cyclophosphamide and Ixazomib Combination Rescues Mice Subjected to Experimental Graft-versus-Host Disease and Is Superior to Either.
Raimon Duran-Struuck, Isao Tawara, Kathi Lowler, Shawn G
IAPs protect host target tissues from graft-versus-host disease in mice by Tomomi Toubai, Corinne Rossi, Katherine Oravecz-Wilson, Chen Liu, Cynthia Zajac,
Roles of CD28, CTLA4, and Inducible Costimulator in Acute Graft-versus-Host Disease in Mice  Jun Li, Kenrick Semple, Woong-Kyung Suh, Chen Liu, Fangping.
IL-17A mediates cutaneous GVHD
Rapamycin inhibits IL-4—induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo by Holger Hackstein, Timucin Taner,
Volume 37, Issue 2, Pages (August 2012)
Abrogation of TGFβ Signaling in T Cells Leads to Spontaneous T Cell Differentiation and Autoimmune Disease  Leonid Gorelik, Richard A Flavell  Immunity 
Presentation transcript:

Acceleration of idiopathic pneumonia syndrome (IPS) in the absence of donor MIP-1α (CCL3) after allogeneic BMT in mice by Angela Panoskaltsis-Mortari, John R. Hermanson, Elizabeth Taras, O. Douglas Wangensteen, Jonathan S. Serody, and Bruce R. Blazar Blood Volume 101(9):3714-3721 May 1, 2003 ©2003 by American Society of Hematology

Acceleration of GVHD-mediated mortality in the absence of donor MIP-1α Acceleration of GVHD-mediated mortality in the absence of donor MIP-1α.Cy/TBI-conditioned B10.BR mice received transplants of C57BL/6 BM (■) plus either MIP-1α+/+ (○) or MIP-1α−/−(●) splenocytes. Acceleration of GVHD-mediated mortality in the absence of donor MIP-1α.Cy/TBI-conditioned B10.BR mice received transplants of C57BL/6 BM (■) plus either MIP-1α+/+ (○) or MIP-1α−/−(●) splenocytes. Recipients of MIP-1α−/− splenocytes had accelerated mortality compared with recipients of MIP-1α+/+ cells. (A) Survival. (B) Weights. Results shown are representative of 2 experiments (n = 10 per group;P < .0007). Angela Panoskaltsis-Mortari et al. Blood 2003;101:3714-3721 ©2003 by American Society of Hematology

Recipients of MIP-1α−/− spleen cells exhibit accelerated lung dysfunction after BMT.Specific lung compliance and total lung capacity were determined at days 3, 5, and 7 after BMT in Cy/TBI-conditioned B10.BR mice receiving C57BL/6 BM plus either MIP-1α+/+ o... Recipients of MIP-1α−/− spleen cells exhibit accelerated lung dysfunction after BMT.Specific lung compliance and total lung capacity were determined at days 3, 5, and 7 after BMT in Cy/TBI-conditioned B10.BR mice receiving C57BL/6 BM plus either MIP-1α+/+ or MIP-1α−/− splenocytes. Mean values are indicated for 6 mice per group, pooled from 2 experiments. *P < .05 vs control. Angela Panoskaltsis-Mortari et al. Blood 2003;101:3714-3721 ©2003 by American Society of Hematology

Recipients of GFP-Tg MIP-1α−/− spleen cells exhibit increased migration into the lung, BALT, and spleen on day 3 after BMT.Lethally irradiated B10.BR (allogeneic) or C57BL/6 (syngeneic) mice received C57BL/6 BM and either GFP-Tg MIP-1α+/+ or GFP-Tg MIP-1α−/... Recipients of GFP-Tg MIP-1α−/− spleen cells exhibit increased migration into the lung, BALT, and spleen on day 3 after BMT.Lethally irradiated B10.BR (allogeneic) or C57BL/6 (syngeneic) mice received C57BL/6 BM and either GFP-Tg MIP-1α+/+ or GFP-Tg MIP-1α−/− spleen cells. Shown are in vivo images (1.9-second exposures) of lung, BALT, and spleen captured at day 1 (Figure 3A) and day 3 (Figure 3B) after BMT with a color camera mounted on a stereomicroscope with a GFP filter (× 10.0 zoom factor and × 0.63 transfer lens). “Control” indicates recipient mice receiving allogeneic BM only; images are similar to those of mice receiving syngeneic BM only. Tissues from 1 mouse (of 3 mice) per group per time point are shown. Angela Panoskaltsis-Mortari et al. Blood 2003;101:3714-3721 ©2003 by American Society of Hematology

Acceleration of donor T-cell expansion in the spleens of recipients of MIP-1α−/− cells.Expression of CD4, CD8, and donor haplotype H2bwas determined using flow cytometry and staining with FITC- and PE-labeled mAbs. Acceleration of donor T-cell expansion in the spleens of recipients of MIP-1α−/− cells.Expression of CD4, CD8, and donor haplotype H2bwas determined using flow cytometry and staining with FITC- and PE-labeled mAbs. Values for individual mice are shown and the mean for each group (n = 6, from 2 experiments) is indicated by a bar. “Total number of cells” refers to the total number of nucleated cells of donor or host origin. *P < .05 vs MIP-1α+/+ group. Angela Panoskaltsis-Mortari et al. Blood 2003;101:3714-3721 ©2003 by American Society of Hematology

Acceleration of T-cell influx in the lungs of recipients of MIP-1α−/− cells.Expression of Mac-1, CD4, CD8, and Gr-1 was determined by immunoperoxidase staining of cryosections with biotinylated mAbs. Acceleration of T-cell influx in the lungs of recipients of MIP-1α−/− cells.Expression of Mac-1, CD4, CD8, and Gr-1 was determined by immunoperoxidase staining of cryosections with biotinylated mAbs. Mean values ± SE are indicated for 6 mice per group, pooled from 3 experiments. *P < .05 vs MIP-1α+/+ group. Angela Panoskaltsis-Mortari et al. Blood 2003;101:3714-3721 ©2003 by American Society of Hematology

Accelerated influx of cytolytic granzyme B+cells in the lungs of recipients of MIP-1α−/− spleen cells.Frequencies of cells expressing granzyme B mRNA were determined by in situ hybridization of cryosections with digoxigenin-labeled antisense RNA probes. Accelerated influx of cytolytic granzyme B+cells in the lungs of recipients of MIP-1α−/− spleen cells.Frequencies of cells expressing granzyme B mRNA were determined by in situ hybridization of cryosections with digoxigenin-labeled antisense RNA probes. (A) Mean values ± SE for 4 mice per group, pooled from 2 experiments. *P < .02 vs MIP-1α+/+recipients. (B) In situ hybridizations for granzyme B for one mouse lung representative of each group shown in panel A for days 3 and 7 after BMT (× 200 magnification). Angela Panoskaltsis-Mortari et al. Blood 2003;101:3714-3721 ©2003 by American Society of Hematology

Decreased expression of MIP-1β and RANTES in BAL fluid of MIP-1α−/− spleen cell recipients on day 7 after allogeneic BMT.Protein levels of MIP-1α, MIP-1β, and RANTES were determined by ELISA. Mean values ± SD are indicated for 6 mice per group, pooled from ... Decreased expression of MIP-1β and RANTES in BAL fluid of MIP-1α−/− spleen cell recipients on day 7 after allogeneic BMT.Protein levels of MIP-1α, MIP-1β, and RANTES were determined by ELISA. Mean values ± SD are indicated for 6 mice per group, pooled from 3 experiments. *P < .05 vs MIP-1α+/+ group. Angela Panoskaltsis-Mortari et al. Blood 2003;101:3714-3721 ©2003 by American Society of Hematology

Decreased systemic levels of the anti-inflammatory cytokine IL-13 in serum of MIP-1α−/− spleen cell recipients on day 7 after allogeneic BMT.Protein levels of IL-13 were determined by ELISA. Mean values ± SD are indicated for 6 mice per group, pooled from 3... Decreased systemic levels of the anti-inflammatory cytokine IL-13 in serum of MIP-1α−/− spleen cell recipients on day 7 after allogeneic BMT.Protein levels of IL-13 were determined by ELISA. Mean values ± SD are indicated for 6 mice per group, pooled from 3 experiments. *P < .05 vs MIP-1α+/+ group. Angela Panoskaltsis-Mortari et al. Blood 2003;101:3714-3721 ©2003 by American Society of Hematology